Robustness of automated hippocampal volumetry across magnetic resonance field strengths and repeat images

Alzheimer's and Dementia

Volumn 10, Issue 4, 2014, Pages 430-438.e2

  Wolz, Robin ^a,b   Schwarz, Adam J ^c   Yu, Peng ^c   Cole, Patricia E ^c   Rueckert, Daniel ^b   Jack Jr , Clifford R ^d   Raunig, David ^e   Hill, Derek ^a  

^a IXICO PLC   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ELI LILLY AND COMPANY   (United States)

^d MAYO CLINIC   (United States)

^e ICON Medical Imaging   (United States)

Author keywords

Alzheimer's disease; Clinical trials; Hippocampus; Reproducibility; Segmentation; Test retest

Indexed keywords

AGED; ALGORITHM; ALZHEIMER DISEASE; ARTICLE; AUTOMATION; CONTROLLED STUDY; DIAGNOSIS RELATED GROUP; FEMALE; HIPPOCAMPAL VOLUMETRY; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPRODUCIBILITY; STANDARDIZATION; TEST RETEST RELIABILITY; VOLUMETRY; COMPUTER ASSISTED DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; MENTAL HEALTH; MILD COGNITIVE IMPAIRMENT; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALGORITHMS; ALZHEIMER DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HIPPOCAMPUS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MILD COGNITIVE IMPAIRMENT; REPRODUCIBILITY OF RESULTS;

EID: 84903588356     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2013.09.014     Document Type: Article

References (46)

1. Alzheimer's Disease International World Alzheimer report 2009 2009 Alzheimer's Disease International London
2. C.R. Jack Jr., R.C. Petersen, Y. Xu, P.C. O'Brien, G.E. Smith, and R.J. Ivnik et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD Neurology 55 2000 484 490
3. N.C. Fox, S. Cousens, R. Scahill, R.J. Harvey, and M.N. Rossor Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects Arch Neurol 57 2000 339 344
4. C. Van Petten Relationship between HCV and memory ability in healthy individuals across the lifespan: review and meta-analysis Neuropsychologia 42 2004 1394 1413
5. N. Schuff, N. Woerner, L. Boreta, T. Kornfield, L.M. Shaw, and J.Q. Trojanowski et al. MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers Brain 132 2009 1067 1077
6. H.S. Soininen, K. Partanen, A. Pitkanen, P. Vainio, T. Hänninen, and M. Hallikainen et al. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory Neurology 44 1994 1660 1668
7. R. Wolz, P. Aljabar, J.V. Hajnal, A. Hammers, and D. Rueckert LEAP: Learning Embeddings for Atlas Propagation Neuroimage 49 2010 1316 1325
8. H. Braak, and E. Braak Neuropathological staging of Alzheimer-related changes Acta Neuropathol 82 1999 239 259
9. M. Bobinski, M.J. de Leon, J. Wegiel, S. DeSanti, A. Convit, and L.A. Saint Louis et al. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease Neuroscience 95 1999 721 725
10. C. Jack Jr., D. Knopman, W. Jagust, L. Shaw, and P. Aisen et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol 27 2010 685 691
11. C.R. Jack, P. Vemuri, H.J. Wiste, S.D. Weigand, P.S. Aisen, and J.Q. Trojanowski et al. Evidence for ordering of Alzheimer disease biomarkers Arch Neurol 68 2011 1526 1535
12. A. Convit, M.J. De Leon, C. Tarshish, S. De Santi, W. Tsui, and H. Rusinek et al. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease Neurobiol Aging 18 1997 131 138
13. K.M. Gosche, J.A. Mortimer, C.D. Smith, W.R. Markesbery, and D.A. Snowdon Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study Neurology 58 2002 1476 1482
14. C.R. Jack Jr., R.C. Petersen, Y.C. Xu, P.C. O'Brien, G.E. Smith, and R.J. Ivnik et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment Neurology 52 1999 1397 1403
15. H. Hampel, R. Frank, K. Broich, S. Teipel, J. Katz, and R.G. Hardy et al. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives Nat Rev Drug Discovery 9 2010 560 574
16. NeuroQuant. Available at: http://www.cortechs.net/products/neuroquant. php. Accessed January 17, 2014.
17. Assessa. Available at: http://www.myassessa.com/. Accessed January 17, 2014.
18. D.L.G. Hill, A.J. Schwarz, M. Isaac, L. Pani, S. Vamvakas, and R. Hemmings et al. CAMD/EMA biomarker qualification of hippocampal volume for enrichment of clinical trials in pre-dementia stages of Alzheimer's disease Alzheimers Dement 2013 [in press]
19. Qualification process for drug development tools: draft guidance. October 2010. Available at: http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM230597.pdf. Accessed January 17, 2014.
20. J. Woodcok, and R. Woosley The FDA Critical Path Initiative and its influence on new drug development Annu Rev Med 59 2008 1 12
21. G.B. Frisoni, and C.R. Jack Harmonization of magnetic resonance-based manual hippocampal segmentation: a mandatory step for wide clinical use Alzheimer Dement 7 2011 171 174
22. B. Fischl, D.H. Salat, E. Busa, M. Albert, M. Dieterich, and C. Haselgrove Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain Neuron 33 2002 341 355
23. O.T. Carmichael, H.A. Aizenstein, S.W. Davis, J.T. Becker, P.T. Thompson, and C.C. Meltzer et al. Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment Neuroimage 27 2005 979 990
24. M. Chupin, A.R. Mukuna-Bantumbakulu, D. Hasboun, E. Bardinet, S. Baillet, and S. Kinkingnéhun Anatomically constrained region deformation for the automated segmentation of the hippocampus and the amygdala: method and validation on control subjects and patients with Alzheimer's disease Neuroimage 34 2007 996 1019
25. K.K. Leung, J. Barnes, G.R. Ridgway, J.W. Bartlett, M.J. Clarkson, and K. Macdonald et al. Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease Neuroimage 51 2010 1345 1359
26. J. Lötjönen, R. Wolz, J. Koikkalainen, V. Julkunen, L. Thurfjell, and R. Lundqvist Fast and robust extraction of hippocampus from MR images for diagnostics of Alzheimer's disease Neuroimage 56 2011 185 196
27. S.J.B. Vos, I.A. van Rossum, F. Verhey, D.L. Knol, H. Soininen, and L.O. Wahlund et al. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI Neurology 80 2013 1124 1132
28. S.G. Mueller, M.W. Weiner, L.J. Thal, R.C. Petersen, C. Jack, and W. Jagust et al. The Alzheimer's Disease Neuroimaging Initiative Neuroimag Clin North Am 15 2005 869 877
29. C.R. Jack Jr., R.C. Petersen, Y. Xu, P.C. O'Brien, G.E. Smith, and R.J. Ivnik et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease Neurology 51 1998 993 999
30. J. Jovicich, S. Czanner, X. Han, D. Salat, A. van der Kouwe, and B. Quinn et al. MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: reliability effects of image sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths Neuroimage 46 2009 177 192
31. A. Pfefferbaum, T. Rohlfing, M.J. Rosenbloom, and E.V. Sullivan Combining Atlas-based parcellation of regional brain data acquired across scanners at 1.5T and 3.0T field strengths Neuroimage 60 2012 940 951
32. C.R. Jack Jr., M.A. Bernstein, N.C. Fox, P. Thompson, G. Alexander, and D. Harvey et al. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods J Magn Reson Imag 27 2008 685 691
33. Alzheimer's Disease Neuroimaging Initiative. Available at: http://adni.loni.usc.edu/. Accessed on January 17, 2014.
34. N.J. Tustison, B.B. Avants, P.A. Cook, Y. Zheng, E. Egan, and P.A. Yushkevich et al. N4ITK: improved N3 bias correction IEEE Trans Med Imag 29 2010 1310 1320
35. R. Wolz, R.A. Heckemann, P. Aljabar, J.V. Hajnal, A. Hammers, and J. Lötjönen et al. Measurement of hippocampal atrophy using 4D graph-cut segmentation: application to ADNI Neuroimage 52 2010 109 118
36. N. Rajaratnam Reliability formulas for independent decision data when reliability data are matched Psychometrika 25 1960 261 271
37. P.E. Shrout, and J.L. Fleiss Intraclass correlations: uses in assessing rater reliability Psychol Bull 86 1979 420 448
38. R.V. Hogg, and J. Ledolter Engineering statistics 1987 MacMillan New York
39. J.D. Gibbons Nonparametric statistical inference 1985 Marcel Dekker New York
40. IXI Dataset. Available at: http://biomedic.doc.ic.ac.uk/brain- development/index.php?n=Main.Datasets. Accessed on January 17, 2014.
41. K.O. McGraw, and S.P. Wong Forming inferences about some intraclass correlation coefficients Psychol Methods 1 1996 30 46
42. J.M. Bland, and D.G. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1986 307 310
43. J.L. Gunter, M.A. Bernstein, B.J. Borowski, C.P. Ward, P.J. Britson, and J.P. Felmlee et al. Measurement of MRI scanner performance with the ADNI phantom Med Phys 36 2009 2193 2205
44. B.T. Wyman, D.J. Harvey, K. Crawford, M.A. Bernstein, O. Carmichael, and P.E. Cole et al. Standardization of analysis sets for reporting results from ADNI MRI data Alzheimer Dement 9 2013 332 337
45. C.R. Jack Jr., F. Barkhof, M.A. Bernstein, M. Cantillon, P.E. Cole, and C. DeCarli et al. Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease Alzheimers Dement 7 2011 474 485
46. K.K. Leung, J. Barnes, M. Modat, G.R. Ridgway, J.W. Bartlett, and N.C. Fox et al. Brain MAPS: an automated, accurate and robust brain extraction technique using a template library Neuroimage 55 2011 1091 1108